|
DE2945530A1
(de)
|
1979-11-10 |
1981-06-04 |
Chemische Werke Hüls AG, 4370 Marl |
Harnstoffe mit cyclischen substituenten, ihre herstellung und verwendung als herbizide
|
|
JPH03160438A
(ja)
|
1989-11-20 |
1991-07-10 |
Konica Corp |
ハロゲン化銀カラー写真感光材料
|
|
EP0442448A3
(en)
|
1990-02-13 |
1992-08-12 |
Bristol-Myers Squibb Company |
Heterocyclic carboxylic acids and esters
|
|
CA2085844A1
(en)
|
1991-12-27 |
1993-06-28 |
Nobuyuki Hamanaka |
Fused benzeneoxyacetic acid derivatives
|
|
JPH06329598A
(ja)
|
1993-05-19 |
1994-11-29 |
Daicel Chem Ind Ltd |
エステルの製造方法
|
|
DE4318889A1
(de)
|
1993-06-07 |
1994-12-08 |
Bayer Ag |
Verfahren zur Herstellung von organischen Carbamaten
|
|
TW282456B
(https=)
|
1994-03-10 |
1996-08-01 |
Fujisawa Yakusin Kogyo Kk |
|
|
JPH11269138A
(ja)
|
1998-03-20 |
1999-10-05 |
Mitsubishi Paper Mills Ltd |
有機塩基発生剤
|
|
US6335459B1
(en)
|
1998-12-23 |
2002-01-01 |
Syntex (U.S.A.) Llc |
Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
|
|
EP1046631A1
(en)
|
1999-04-19 |
2000-10-25 |
Rolic AG |
Liquid crystalline compounds
|
|
GB9908934D0
(en)
|
1999-04-19 |
1999-06-16 |
Rolic Ag |
Liquid crystalline compounds
|
|
US20040048844A1
(en)
|
1999-10-20 |
2004-03-11 |
Bristol-Myers Squibb Pharma Company |
Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
|
|
KR100523119B1
(ko)
|
2000-03-16 |
2005-10-20 |
에프. 호프만-라 로슈 아게 |
Ｉｐ 길항제로서의 카복실산 유도체
|
|
WO2002055484A1
(en)
|
2001-01-12 |
2002-07-18 |
Takeda Chemical Industries, Ltd. |
Biaryl compound, process for producing the same, and agent
|
|
TWI316055B
(https=)
|
2001-04-26 |
2009-10-21 |
Nippon Shinyaku Co Ltd |
|
|
WO2003007888A2
(en)
|
2001-07-20 |
2003-01-30 |
Adipogenix, Inc. |
Fat accumulation-modulating compounds
|
|
CN101284773A
(zh)
|
2001-08-09 |
2008-10-15 |
小野药品工业株式会社 |
羧酸衍生物及以它为活性成分的药剂
|
|
TW200307539A
(en)
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
|
TWI293715B
(en)
|
2002-10-10 |
2008-02-21 |
Sipix Imaging Inc |
A method for inducing or enhancing the threshold of an electrophoretic display, an electrophoretic fluid and an electrophoretic display
|
|
CN1735598A
(zh)
|
2002-11-11 |
2006-02-15 |
拜耳医药保健股份公司 |
作为ip受体拮抗剂的苯基或杂芳基氨基烷烃衍生物
|
|
RU2351590C2
(ru)
|
2003-02-10 |
2009-04-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ получения диариламина
|
|
GB0317498D0
(en)
|
2003-07-25 |
2003-08-27 |
Pfizer Ltd |
Compounds
|
|
JP4339890B2
(ja)
|
2003-09-22 |
2009-10-07 |
エフ．ホフマン−ラ ロシュ アーゲー |
アミノアルキルアミド置換シクロヘキシル誘導体
|
|
JP4402413B2
(ja)
|
2003-09-29 |
2010-01-20 |
財団法人２１あおもり産業総合支援センター |
Ｕ字型化合物およびこれを含む液晶組成物
|
|
DE102004006785A1
(de)
|
2004-02-11 |
2005-09-08 |
Mayr, Herbert, Prof. Dr. |
Verfahren zur CC-Bindungsknüpfung zwischen elektrophilen Substraten und TT-Verbindungen in neutralen bis basischen wässrigen oder alkoholischen Lösungsmitteln ohne den Einsatz einer Lewis- oder Protonensäure
|
|
JP2008510726A
(ja)
|
2004-08-20 |
2008-04-10 |
エントレメッド インコーポレイテッド |
プロテイナーゼ活性化受容体アンタゴニストを含む組成物および方法
|
|
JP2006083085A
(ja)
|
2004-09-15 |
2006-03-30 |
Kyowa Hakko Kogyo Co Ltd |
二環性ピリミジン誘導体の製造法およびその合成中間体
|
|
JP4792731B2
(ja)
|
2004-11-12 |
2011-10-12 |
Ｄｉｃ株式会社 |
重合性液晶組成物及び当該組成物の硬化物
|
|
WO2007051255A1
(en)
|
2005-11-04 |
2007-05-10 |
The University Of Sydney |
Process for the preparation of compounds containing an azacyclic ring system
|
|
JP2007161867A
(ja)
|
2005-12-14 |
2007-06-28 |
Toyo Ink Mfg Co Ltd |
インキ組成物
|
|
US20080075692A1
(en)
|
2006-05-09 |
2008-03-27 |
Perrine Susan P |
Methods for treating blood disorders
|
|
WO2009117095A1
(en)
|
2008-03-18 |
2009-09-24 |
Arena Pharmaceuticals, Inc. |
Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
|
|
US20110224262A1
(en)
|
2008-11-26 |
2011-09-15 |
Arena Pharmaceuticals, Inc. |
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
|
|
ES2548882T3
(es)
|
2008-12-08 |
2015-10-21 |
Arena Pharmaceuticals, Inc. |
Moduladores del receptor de prostaciclina (PGl2) útiles para el tratamiento de trastornos relacionados con los mismos
|
|
WO2011037613A1
(en)
|
2009-09-23 |
2011-03-31 |
Arena Pharmaceuticals, Inc. |
Crystalline forms and processes for the preparation of pgi2 receptor agonists
|
|
US10537546B2
(en)
|
2014-10-23 |
2020-01-21 |
Arena Pharmaceuticals, Inc. |
Method of treating conditions related to the PGI2 receptor
|
|
US12377067B2
(en)
|
2016-11-10 |
2025-08-05 |
Arena Pharmaceuticals, Inc. |
Methods of treating PAH with combinations of ralinepag and other agents
|
|
IL268997B2
(en)
|
2017-03-01 |
2023-09-01 |
Arena Pharm Inc |
Preparations containing pgi2 receptor agonists and processes for their preparation
|
|
CA3072079A1
(en)
|
2017-08-07 |
2019-02-14 |
Arena Pharmaceuticals, Inc. |
Methods of treatment
|
|
EP3796902A1
(en)
|
2018-05-16 |
2021-03-31 |
Arena Pharmaceuticals, Inc. |
Compositions comprising pgi2-receptor agonists and processes for the preparation thereof
|
|
WO2020048299A1
(zh)
|
2018-09-06 |
2020-03-12 |
广东东阳光药业有限公司 |
药物共晶体及其制备方法
|
|
WO2023158634A1
(en)
|
2022-02-15 |
2023-08-24 |
United Therapeutics Corporation |
Crystalline prostacyclin (ip) receptor agonist and uses thereof
|
|
AU2023236147A1
(en)
|
2022-03-17 |
2024-09-19 |
United Therapeutics Corporation |
Ralinepag prodrugs and uses thereof
|